RCM
CRSP icon

Raleigh Capital Management’s CRISPR Therapeutics CRSP Stock Holding History

Raleigh Capital Management’s Portfolio CRSP Stock Details CRSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-50
Closed -$3.41K – 997
2024
Q1 		$3.41K Buy
+50
New +$3.41K ﹤0.01% 705